Fundamental Analysis of KODIAK SCIENCES INC(NASDAQ:KOD) stock

Fundamental Rating

Taking everything into account, KOD scores 2 out of 10 in our fundamental rating. KOD was compared to 568 industry peers in the Biotechnology industry. The financial health of KOD is average, but there are quite some concerns on its profitability. KOD has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

KOD had negative earnings in the past year.

In the past year KOD has reported a negative cash flow from operations.

KOD had negative earnings in each of the past 5 years.

KOD had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -51.42%, KOD perfoms like the industry average, outperforming 47.61% of the companies in the same industry.

KOD has a Return On Equity (-103.37%) which is in line with its industry peers.

		Industry Rank	Sector Rank
ROA	-51.42%
ROE	-103.37%
ROIC	N/A

ROA(3y)-44.65%

ROA(5y)-31.92%

ROE(3y)-71.6%

ROE(5y)-48.79%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

KOD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

KOD has more shares outstanding than it did 1 year ago.

KOD has more shares outstanding than it did 5 years ago.

There is no outstanding debt for KOD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

KOD has an Altman-Z score of -4.56. This is a bad value and indicates that KOD is not financially healthy and even has some risk of bankruptcy.

KOD has a worse Altman-Z score (-4.56) than 60.18% of its industry peers.

KOD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-4.56

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 8.42 indicates that KOD has no problem at all paying its short term obligations.

KOD has a Current ratio of 8.42. This is in the better half of the industry: KOD outperforms 74.34% of its industry peers.

A Quick Ratio of 8.42 indicates that KOD has no problem at all paying its short term obligations.

With a decent Quick ratio value of 8.42, KOD is doing good in the industry, outperforming 74.51% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	8.42
Quick Ratio	8.42

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

KOD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.54%, which is quite impressive.

EPS 1Y (TTM)29.54%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%11.58%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

KOD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.63% yearly.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y30.89%

EPS Next 2Y12.5%

EPS Next 3Y7.51%

EPS Next 5Y7.63%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KOD. In the last year negative earnings were reported.

Also next year KOD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y12.5%

EPS Next 3Y7.51%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for KOD!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KODIAK SCIENCES INC

NASDAQ:KOD (12/18/2024, 6:20:22 PM)

After market: 9 +0.25 (+2.86%)

8.75

-0.12 (-1.35%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap460.43M

Analysts

Price Target

Short Float %

Short Ratio

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-51.42%
ROE	-103.37%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	8.42
Quick Ratio	8.42
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)29.54%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y30.89%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

KODIAK SCIENCES INC (KOD)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens